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Aim: Rapid maxillary expansion is performed to correct a skeletal transverse deficiency of the maxilla, which is a frequently-
encountered orthodontic anomaly. Strontium ranelate (SrR) is a novel agent that has a dual action, involving anti-resorptive and 
bone-forming effects. The aim of this study was to evaluate the effects of systemically applied SrR on osteoblastic bone formation 
after maxillary expansion on the mid-palatal suture of rats using histological and immunohistochemical tests.
Materials and methods: A total of 24 Wistar rats were randomly divided into two equal groups. In all animals, five-day inter-
premaxillary expansion was applied and maintained for a seven-day retention period, during which 625mg/kg/day SrR diluted 
with saline solution was administered orally to the experimental group. The rats were sacrificed and the tissues prepared for 
histological and immunohistochemical examinations after the retention period.
Results: Osteoblastic activity and the width of the blood vessels in the suture area were significantly increased in the SrR group 
compared with the control group (p < 0.05). Ossification was also observed to be active under light microscopy by staining with 
hematoxylin and eosin in the experimental group. Immunohistochemical labelling performed using osteonectin, osteocalcin, TGF-β 
and VEGF antibodies revealed significant immunoreactivity in the experimental group (p < 0.05). 
Conclusion: It may be concluded that SrR contributed to stimulatory osteogenesis in the expansion region. Therefore, a retention 
period may be shortened and relapse possibly reduced, following the application of SrR after the expansion.
(Aust Orthod J 2016; 32: 139-147)
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Introduction
Orthodontists commonly apply forces on facial 
sutures to overcome transverse maxillary deficiencies 
by stimulating bone deposition. Rapid maxillary 
expansion is the primary treatment approach to correct 
malocclusions caused by a narrow maxillary dental 
arch and skeletal base deficiency. After expansion, a 
series of biological events occurs, in which sutures 
undergo remodelling identified by bone formation, 
resorption, and fibre rearrangement in the expanded 
area.1 This process continues until the architectural 
bony environment reaches equilibrium.2 It has been 
well documented that, even after a retention period, an 
expanded maxillary dental arch has a strong tendency 
to rebound to its previous state.3-5 Relapse rates after 
retention have been reported between 0% and 45%,5-7 
so long retention periods are usually necessary to avoid 
potential post-treatment change. Da Silva Filho et al.8 
investigated the expanded suture by computerised 
tomography after the application of a conventional 
six-month retention period and concluded that 
the mid-palatal suture in humans was fully ossified 
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along its length. The growth rate of new bone and 
the acceleration of bone formation in the mid-palatal 
suture after expansion are essential to limit subsequent 
relapse of the arch width and to shorten the retention 
period.9-12 Consequently, research has focused on the 
maintenance of maxillary expansion. The stimulation 
of bone formation in the expanded suture has been 
studied by the application of external factors, such as 
low-power laser irradiation9 and low intensity pulsed 
ultrasound (LIPUS),10 transforming growth factor-β 
(TGF-β) 1 injection11 or with chemical factors, such 
as antioxidants, bisphosphonates and a vitamin D 
analog.12-15
Strontium ranelate (SrR) is a novel oral anti-
osteoporotic agent. In clinical trials, SrR has shown 
potential in the treatment of osteoporosis and reducing 
the risk of vertebral and non-vertebral fractures in 
post-menopausal osteoporotic women.16,17 Many bone 
resorption inhibitors have been developed to decrease 
the risk of osteoporotic fractures, including SrR, which 
has a dual effect on bone metabolism. Preclinical 
studies have shown that SrR reduces bone resorption 
and stimulates bone formation concomitantly in the 
remodelling areas.18,19 Bone formation and bone cell 
replication are stimulated through the amplification 
of pluripotent and pre-osteoblastic mesenchymal cell 
effects. SrR has been shown to reduce bone resorption 
by decreasing osteoclast differentiation and bone 
resorbing activity.20
SrR has been systemically used to accelerate fresh 
fracture healing,21 increase bone proliferation,22 treat 
osteoporosis,23 increase osteo-integration24 and reduce 
the risk of fracture formation.25 However, to the best 
of our knowledge, there has been no study on the use 
of SrR after maxillary expansion. 
Therefore, the objective of the present study was to 
evaluate the effect of SrR on osteoblastic activity in 
the mid-palatal suture of rats after expansion, and 
thereby contribute to the understanding of strategies 
for preventing relapse after treatment. The null 
hypothesis states that the administration of SrR has 
positive effects on bone formation following inter-
premaxillary suture expansion in rats.
Materials and methods
Animals and groups
To determine the sample size of this study, G Power 
software version 3.1.9.2 (Franz Faul, University of 
Kiel, Germany) was used. With a type I error of 0.05 
and a type II error of 0.20, at least 16 animals, each 
in two groups of eight, would be required for a power 
greater than 80%. Therefore, 24 male Wistar rats with 
a mean weight of 200 ± 20 g and mean age of 11–12 
weeks were included in the study and divided into 
two groups of 12 rats: a control and SrR-test groups. 
Both groups underwent five-day maxillary expansion 
followed by a seven-day retention period. The control 
animals received saline solution orally once a day 
via a syringe during the retention period. The study 
group was treated with a dose of SrR (625 mg/kg/day) 
administered orally via a syringe during the seven-day 
retention period. All rats were caged individually at a 
constant temperature of 23oC with a 12 hour light-
dark cycle and fed water and standard rat pellets, ad 
libitum. 
Ethical approval for the study was granted by 
the Animal Research Ethics Committee at İnönü 
University School of Medicine, Malatya, Turkey 
(2012/A-65). The study was conducted in accordance 
with the Declaration of Helsinki, Guiding Principles 
in the Care and Use of Animals in Research.
Interpremaxillary suture expansion
The animals were anaesthetised by one investigator 
with a subcutaneous injection of 4 mg/kg of xylazine 
hydrochloride (Alfazyne; Alfasan International BV, 
Woerden, Netherlands) and 40 mg/kg ketamine 
hydrochloride (Alfamine; Alfasan International BV 
Woerden, Netherlands). Two grooves were prepared 
in the mesial and distal proximal surfaces of the upper 
incisors. The legs of a helical spring made of 0.014 
inch stainless steel wire (Dentaurum, Germany) 
were inserted in the grooves to expand the inter-
premaxillary suture (Figures 1, 2). Pre-activation of 
the spring was conducted to apply a force of nearly 
50 g without further activation. Following expansion, 
the springs were deactivated under general anesthesia 
and left in situ. Using a digital micrometer (Mitituyo, 
Tokyo, Japan), the amount of expansion was measured 
between the distal edges of the upper incisors at two 
time points: prior to expansion (T1) and at the end 
of the expansion (T2). Each parameter was measured 
twice and the average measurement was recorded. 
Specimen preparation
At the end of retention, all rats were sacrificed using 
ketamine hydrochloric and xylazine hydrochloric 
and the rats’ maxilla was surgically dissected for 
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the formalin-fixed, paraffin-embedded tissue blocks 
were evaluated in the Pathology Laboratory of the 
Medical Faculty, University of Necmettin Erbakan in 
Konya, Turkey.
Immunohistochemical staining procedure
After overnight incubator storage at 60°C, sections 
were dewaxed in xylene and rehydrated through a 
series of ethanol solutions. A solution of distilled water 
and phosphate-buffered saline (PBS; P4417, Sigma-
Aldrich, MO, USA) was applied for 10 minutes to 
rinse the sections, which were then treated with 0.1% 
trypsin (Zymed, 00-3008, CA, USA) for 10 minutes 
and washed with PBS. Sections were delineated with 
a PAP pen (Super PAP PEN, IM3580, Beckman 
Coulter, Marseille, France) and incubated with a 
non-immune serum (Ultra V block, cat. No: TA-125-
UD, Lab Vision, CA, USA), followed by incubation 
with the primary antibodies of monoclonal mouse 
anti-osteonectin (SPARC, 251503, Abbiotec, CA, 
USA), monoclonal mouse anti-osteocalcin (OC4-
30, Novus Biologicals, Cambridge, UK), monoclonal 
mouse anti-VEGF (PU483-UP, Biogenex, CA, 
USA) and polyclonal rabbit anti-TGF-β (ab66043, 
Abcam plc, Cambridge, UK), for one hour at 4°C in 
a humidity chamber. The sections were rinsed three 
times in distilled water and PBS for five minutes, and 
subsequently incubated with biotinylated secondary 
antibody followed by streptavidin conjugated to 
horseradish peroxidase in PBS for 30 minutes each 
(Lab. Vision Cat:TS-125-HR, Thermo Scientific, 
MA, USA). After a further three washes with PBS, 
the sections were incubated with Lab. Volume 
diaminobenzidine substrate (Lab. Vision CAT: TS-
125-HR) for 15 minutes for immuno-staining. 
The sections were rinsed with distilled water, 
counterstained with Mayer’s haematoxylin (Lillie’s 
modification, ScyTek Laboratories, UT, USA) and 
rewashed with distilled water before mounting in an 
aqueous medium. 
The sections were examined with a BX 43 bright-field 
microscope (Olympus, Tokyo, Japan). A precipitate 
of reddish-brown colour indicated positive findings 
for the primary antibodies. The staining scores were 
independently evaluated by an observer (S.K.) blinded 
to the clinical information. Semi-quantitative grading 
of the mean values of the immunohistochemical 
staining intensities was graded as mild (+), moderate 
(++), or strong (+++).
Figure 1. Schematic view of the expansion appliance used.
Figure 2. Intra-oral view of the expansion appliance.
assessment. After fixation in 10% neutral buffered 
formalin solution at room temperature for 24 hours, 
decalcification of the premaxilla commenced using 
ethylene diamine tetra-acetic acid (0.1 mol/L, pH 
7.1) solution, which was changed on alternate days 
for three weeks at 14°C. Following decalcification, 
using the maxillary incisor as the primary guide for 
orientation, the inter-premaxillary suture areas were 
excised. The excised tissue was prepared for standard 
histological examination by paraffin embedding and 
slices of 5 µm thickness sectioned in the coronal plane 
and mounted. The prepared sections were stained 
using haematoxylin and eosin, after which, tissue 
specimens were randomly selected and histologically 
evaluated (HE, Harris haematoxylin, 09-182-1, DDK 
Italia, Italy; Eozin, MOS, 0712012, Turkey). All of 
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At 40-times magnification, the number of active 
osteoblasts was scored as + (1–10), ++ (11–20), or 
+++ (>20). The width of the vessels was scored as + 
(narrow), ++ (moderate), or +++ (wide).
Statistical analysis
An analysis of the measurements was conducted 
using the Statistical Package for the Social Sciences 
20.0 (SPSS for Windows, SPSS Inc., Chicago, Ill, 
USA). The normality of the data was evaluated by the 
Shapiro-Wilk test. Descriptive statistics were stated as 
median, minimum, and maximum for ordinal data, 
and as mean and standard deviation for continuous 
data. To evaluate the distance measurements in the 
T1, T2, and T3 periods for group comparisons, the 
Mann-Whitney U test was applied. To assess the 
differences in each group over the various periods, the 
Friedman and Wilcoxon tests were used. Histological 
and immunohistochemical measurements (T3) were 
evaluated with the Freidman and Mann-Whitney U 
tests. A value of p < 0.05 was considered as statistically 
significant.
Results
A temporary reduction in the animal’s body weight 
was seen in the first few days due to the application 
of the expansion and retention appliance. Thereafter, 
the spring was well tolerated and no weight loss was 
observed. The desired sutural opening successfully 
occurred over the five days of the expansion period. 
The mean measurement and standard deviations at 
T1, T2, and T3 are shown in Table I. There were 
significant differences between the two groups at the 
different time periods (T1, T2, T3) and related to the 
width measurements between the distal corners of the 
incisors (p < 0.05). In addition, there were significant 
differences in the distances between the T1–T2 and 
T1–T3 periods (p < 0.05). However, there was no 
significant change between T2 and T3 (p > 0.05) for 
either group. 
There was no statistically significant difference in the 
mean amount of expansion (T1–T2), between the 
two groups (Table II). Both samples were, therefore, 
accepted as similar as no difference was observed in 
the width between the distal corners of the maxillary 
incisors in the animals in each group (Table II).
The histological and immunohistochemical images of 
both groups are shown in Figures 3–7. The sagittal 
suture samples stained with haematoxylin and eosin 
from the SrR group (five-day expansion, strontium 
ranelate, and seven-day retention) under the light mi-
croscope revealed that 11–20 (++) active osteoblasts 
were localised along the suture and the blood vessels 
were evaluated as wide (+++) (Figure 3). In this group, 
strong (+++) osteocalcin, osteonectin, VEGF and 
TGF-β immunoreaction was observed in the osteo-
blasts, and moderate (++) immunoreactivity was ob-
served in the sutural connective tissues (Figures 4 – 7). 
The light microscopic examination of the sagit-
tal suture sections stained with haematoxylin and 
eosin from the control group (five-day expansion 
and seven-day retention) revealed 1–10 (+) active 
osteoblasts localised along the suture, and blood 
vessels were of moderate width (++) (Figure 3). 
In this group, minimal (+) osteocalcin and moderate 
(++) osteonectin immunoreactivities were observed in 
osteoblasts, and minimal (+) immunoreactivity was 
T1 T2 T3 Paired t-test
N Mean SD Mean   SD Mean SD T0-T1 T0-T2 T1-T2
SrR 12 2757.33 78.94 5342.08 128.42 5360.00 203.18 *** *** NS
Control 12 2680,08 87.95 5187.67 70.02 5186.50 77.05 *** *** Ns
Table I. The mean measurement and standard deviations on the caliper measurements of width between the distal corner of the incisor at T1, T2, and T3 (µm).
N: sample size; NS: non-significant; ***: p < 0.001
SrR Control
N Mean SD N Mean SD p value Significance
Amount of expansion 12 2473.8 93.1 12 2389.75 98.13 0.729 NS
Table II. Comparison of biometric analysis for determination of the amount of dental expansion (µm).
N: sample size; p value: independent samples t-test; NS: non-significant
Australian Orthodontic Journal Volume 32 No. 2  November 2016 143
EFFECTS OF STRONTIUM RANELATE ON SUTURAL BONE FORMATION
Figure 4. Photomicrographs of immunohistochemical sections from 
sutural areas stained with anti-osteonectin antibody. Ob: Osteoblastic 
activity; S: Sutura connective tissue (40× magnification).
Figure 5. Photomicrographs of immunohistochemical sections from 
sutural areas stained with anti-osteocalcin antibody. Ob: Osteoblastic 
activity; S: Sutura connective tissue (40× magnification).
Figure 6. Photomicrographs of immunohistochemical sections from 
sutural areas stained with anti-TGF-β antibody. Ob: Osteoblastic 
activity; S: Sutura connective tissue (40× magnification).
Figure 7. Photomicrographs of immunohistochemical sections from 
sutural areas stained with anti-VEGF antibody. Ob: Osteoblastic 
activity; S: Sutura connective tissue (40× magnification).
of inter-premaxillary sutures in rats. If the expansion 
used to treat transverse maxillary discrepancies and 
the retention period is inadequate, there may be a 
reduction in the width of the expanded maxillary 
arch.7 Previous research has examined the application 
of several pharmacological agents to increase bone 
formation. There have also been investigations into 
the stimulation of bone regeneration in the inter-
premaxillary suture after expansion.26 However, 
to the best of current knowledge, this is the first 
experimental study to investigate the effect of SrR on 
inter-premaxillary sutures after maxillary expansion. 
Unlike other available anti-osteoporotic agents, SrR is 
Figure 3. Photomicrographs of histologic sections of sutural areas stained with Hematoxylin and eosin (H&E). 
Ob: Osteoblastic activity; S: Sutura connective tissue; Cp: Capillary; Nb: New bone (A:5×, B:10×, C:20×, 
D:40× magnification).
observed in the suture connective tissues (Figures 4 
and 5). In the control group, moderate (++) VEGF 
and TGF-β immunoreactivity was observed in active 
osteoblasts and minimal (+) immunoreactivity was 
observed in the sutural connective tissues (Figures 6 
and 7).
When the scores of staining intensity were compared, 
a statistically significant increase was found in Group 
1 compared with Group 2 (Tables III and IV).
Discussion
The results of the present study showed that SrR 
stimulated new bone formation after the expansion 
Australian Orthodontic Journal Volume 32 No. 2  November 2016144
KARATAŞ, TOY, DEMIR, TOY AND KOZACIOĞLU
novel and has been shown to induce bone-formation 
and anti-resorption effects in vitro and in vivo. Several 
in vitro studies in models of bone cell resorption and 
formation have been conducted to clarify the effects of 
SrR on bone cells, with evidence indicating that SrR 
is an anti-resorption agent. In mouse calvaria, cultures 
of SrR have been found to inhibit bone resorption by 
approximately 30%, as assessed by calcium release.27 
In addition, from measurements of a resorbing pit 
assay in isolated rat cells, SrR has been shown to 
decrease osteoclast activity by approximately 30%.28 
These data indicate that SrR decreases the activity of 
osteoclasts, induces osteoclast apoptosis and decreases 
osteoclast differentiation, which leads to a decrease in 
bone resorption in vitro.
In addition, there is evidence that SrR has a positive 
effect on bone formation in vitro.17 In isolated 
rat calvaria cells, SrR was found to stimulate 
preosteoblastic cell replication and bone collagen 
synthesis.29 Therefore, in the present study, the 
histological and immunohistochemical effects of 
SrR were investigated on new bone deposition after 
mid-palatal expansion with an osteoblast cell line and 
related bone-specific proteins. The present results 
indicated that SrR increased new bone formation. 
In previous animal model experimental studies, the 
rate of bone mineralisation after the application of 
force has been evaluated. Although the maxillary 
sutures of monkeys and cats are considered to be the 
most similar to those of humans, to achieve a clear 
representation of bony and sutural influences under 
force, the rabbit and the rat are the most suitable 
animals.30 Therefore, rats were selected as the animal 
model in the present study.
The normal premaxillary suture has been reported to 
be approximately 20 µm to 60 µm in thickness, and 
an average opening of 377 ± 104 µm was achieved by 
rubber wedges in a five-day expansion period in young 
rats.31 In the present study, the inter-premaxillary 
suture was expanded by a helical spring. Both SrR and 
control groups were considered to be similar as the 
measurement of width between the distal corners of 
the maxillary incisors did not show any statistically 
significant difference between the two groups.
The capacity of SrR to stimulate bone formation 
and resorption has been reported in previous animal 
studies.32-34 In normal adult mice, SrR (200-1800 mg/
kg/day, two years) administration increased vertebral 
bone formation and decreased bone resorption, which 
 
SrR (N=12) Control (N=12) Mann-Whitney U test
Mean ± SD SE Median Min Max Mean ± SD SE Median Min Max p value Significance
Number of 
Ob 2.16 ± 0.71 0.21 2.00 1.00 3.00 1.33 ± 0.49 0.14 1.00 1.00 2.00 0.006 ***
Vascularity 2.25 ± 0.45 0.13 2.00 2.00 3.00  1.58 ± 0.66 0.19 1.50 1.00 3.00 0.011 **
Table III. Result of histological evaluations.
SrR: Strontium ranelate; Ob: Osteoblast; Min: Minimum; Max: Maximum; SD: Standard deviation; SE: Standard error; **: p < 0.01; ***: p < 0.001 
 
SrR (N=12) Control (N=12)  Pa
Mean ± SD Median Min Max  Mean ± SD Median Min Max p value significance
Osteonectin-osteoblast 2.41 ± 0.66 2.50 1.00 3.00  1.58 ± 0.66 1.50 1.00 3.00 0.09 *
Osteonectin-fibrous tissue 1.41 ± 0.51 1.00 1.00 2.00 1.08 ± 0.28 1.00 1.00 2.00 0.06 NS
Osteocalcin-osteoblast 2.08 ± 0.90 2.00 1.00 3.00  1.66 ± 0.77 1.50 1.00 3.00 0.24 NS
Osteocalcin-fibrous tissue 1.25 ± 0.45 1.00 1.00 2.00 1.16 ± 0.38 1.00 1.00 2.00 0.62 NS
VGEF-osteoblast 2.83 ± 0.38 3.00 2.00 3.00  2.00 ± 0.85 2.00 1.00 3.00 0.01 **
VGEF-fibrous tissue 1.91 ± 0.79 2.00 1.00 3.00 1.25 ± 0.45 1.00 1.00 2.00 0.02 *
TGF-β-osteoblast 2.41 ± 0.79 3.00 1.00 3.00  1.75 ± 0.75 2.00 1.00 3.00 0.04 *
TGF-β-fibrous tissue 1.25 ± 0.45 1.00 1.00 2.00 1.16 ± 0.38 1.00 1.00 2.00 0.62 NS
SrR: Strontium ranelate; NS: Non-significance; *: p < 0.05; Max: Maximum; Min: Minimum; SE: Standard error; SD: Standard deviation; Pa: Mann-
Whitney U test
Table IV. Result of immunohistochemical evaluations.
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resulted in increased bone mass.35 The most affirmative 
effect of SrR on bone mass in rats was achieved with 
a dose of 225–900 mg/kg for its anti-resorption and 
bone forming activity for improved bone strength.34 
SrR also increased the extent of mineralising surfaces.4 
Therefore, the dose of 625mg/kg SR was selected for 
the present study.
The application of several chemical and pharmaco-
logical agents to improve new bone formation in the 
expanded mid-palatal sutures has been studied previ-
ously.9-11,26,36 Saito and Shimizu9 evaluated the effects 
of low-power laser irradiation on bone regeneration 
during expansion of the mid-palatal suture in rats and 
suggested that laser therapy has the advantage of in-
hibiting relapse and shortening the retention period 
through acceleration of bone regeneration.
Alternatively, researchers applied vitamin E injections 
at the end of the expansion of the inter-premaxillary 
suture to evaluate the effect on bone regeneration, 
and it was determined that vitamin E application 
stimulated bone formation and shortened the retention 
period.36 More recently, in a study by Öztürk et al.,13 
the effects on sutural new bone formation and relapse 
were evaluated after expansion and the application of 
injected bisphosphonates in rats. Positive outcomes 
were observed in the stimulation of bone regeneration 
and a decrease in the relapse ratio. However, after 
tooth extraction, an association was found between 
bisphosphonate therapy and jaw osteonecrosis.37 As 
a comparison, it may be accepted that SrR has an 
important advantage over other available invasive 
treatment modalities, because of its dual action on 
bone regeneration and minimal side effects.
Immunohistochemical staining is one of the most 
widely known and used methods to determine 
osteoblastic activity and therefore, in the present 
study, osteonectin, osteocalcin, VEGF and TGF-β 
were mainly investigated.11,13,38 Osteonectin is a 
bone-specific protein with the capacity to specifically 
bind to hydroxyapatite and collagen.39 In the current 
study, there was a statistically significant difference 
between the groups related to osteonectin activity 
(p < 0.05). Öztürk et al.13 indicated that, with the 
application of bisphosphonate in an expanded suture, 
osteocalcin activity was increased. Since osteocalcin, 
present in bone and dentin as a non-collagenous 
protein,39 plays an active role in regulating the process 
of ossification, extra-cellular matrix remodelling and 
maturation, it is not unexpected that the intensity 
of bone mineralisation increases when osteocalcin 
activity is higher than normal. After SrR application 
in the present study, there was a significant increase in 
osteocalcin activity.
VEGF is a glycoprotein growth factor that has been 
shown to have major effects on tissue formation, cell 
migration, and inflammation and wound healing.40 
Öztürk et al.13 investigated the effects of zoledronic 
acid (ZA) on the production of VEGF by odontoblast-
like cells and reported that ZA accelerated the level 
of VEGF and that there might be an autocrine effect 
generated by VEGF on these cells. These findings 
were consistent with the results of the present study. 
The results showing significantly increased staining 
of osteocalcin, TGF-β and VEGF in the mineralised 
tissue of the tested samples may indicate significant 
proliferative cellular immunoreactivity following the 
application of SrR.
In the present study, the number of osteoblasts and 
the width of vessels in the SrR-applied group were 
observed to have histologically increased compared 
with the control group. 
Moreover, the data obtained along the suture and the 
vascular effects in the SrR group are consistent with 
increased immunoreactivity of osteoblasts in that 
area compared with the control group. The effect of 
an increased number of osteoblasts in the SrR group 
also seems to mirror the effects of agents reported in 
previous studies.6,12,13,20,25,41,42
Öztürk et al.13 showed an increased immunoreactivity 
of osteoblasts in the suture area compared with 
control groups and determined that ZA in the suture 
contributed to new bone formation (p < 0.05). When 
the results of the indirect immunohistochemical 
staining using osteonectin, VEGF and TGF-β in the 
test group of the present study were compared with 
those of Öztürk et al.,13 similar findings of osteoblast 
immunoreactivity were observed. This result suggests 
that strontium ranelate could be effective in the 
ossification of the rat sutures. 
Several studies have been conducted related to the effect 
of strontium ranelate on increasing bone formation 
and reducing destruction. Ozturan et al.21 investigated 
the effect of SrR on fracture healing in rats and found 
that SrR caused a significant increase in bone mineral 
density (BMD), mechanical strength, callus maturity 
and the numbers of osteoblasts. Brüel et al.43 evaluated 
the effects of systemically-administered SrR on bone 
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mineral density and bone mineral content in healthy 
rats and showed that SrR is safe and improves bone 
resistance by increasing bone mass and improving its 
architecture while maintaining bone rigidity.
The results of the present study demonstrated that 
the SrR-applied group had statistically significant 
increases in osteoblast numbers and immunoreactivity 
in the suture region, compared with the other groups. 
This report is the first study to examine the effect 
of SrR on the inter-premaxillary suture after rapid 
maxillary expansion. However, the use of SrR in 
human children for the purpose of reducing relapse of 
rapid palatal expansion may be ethically questionable.
Conclusions
The present findings suggest that systemically-admin-
istered strontium ranelate can stimulate new bone 
formation. Furthermore, a 625 mg/kg concentration 
of SrR therapy daily was an effective dose for bone re-
generation in rats. Therefore, systemic administration 
of SrR may be helpful in the prevention of relapse fol-
lowing a maxillary expansion procedure. These results 
suggest the possibility of pharmaceutically-assisted 
retention to maintain the outcome of sutural mecha-
notherapy in clinical orthodontics. It was also shown 
that oral administration of SrR can be considered to 
be relatively safe. However, further research is needed 
to answer the following questions:
1. Does the short-term SrR usage stimulate more 
bone in maxillary expansion in humans?
2. Does the short-term increased bone production 
decrease long-term relapse after maxillary suture 
expansion in rats and humans?
3. Does short-term SrR therapy decrease tooth 
movement?
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